Caribou Biosciences, Inc. (CRBU)
1.97
+0.06
(+3.14%)
USD |
NASDAQ |
Mar 19, 16:00
1.98
+0.01
(+0.51%)
After-Hours: 20:00
Caribou Biosciences EPS Diluted (Quarterly) : -0.2802 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EyePoint Plc | -0.8143 |
| SELLAS Life Sciences Group, Inc. | -0.0626 |
| GT Biopharma, Inc. | -4.413 |
| Aclaris Therapeutics, Inc. | -0.1614 |
| CytomX Therapeutics, Inc. | -0.1734 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.49M |
| Revenue (Quarterly) | 3.941M |
| Total Expenses (Quarterly) | 30.43M |
| Enterprise Value | 78.26M |
| Gross Profit Margin (Quarterly) | 82.69% |
| Profit Margin (Quarterly) | -672.1% |
| Earnings Yield | -80.63% |
| Normalized Earnings Yield | -72.80 |